Using 6-Min Walk Distance Expressed as a Percentage of Reference to Evaluate the Effect of Pulmonary Rehabilitation in Elderly Patients with Interstitial Lung Disease

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 38, Issue 5, 2018, Pages 342-347

  Igarashi, Ai ^a   Iwanami, Yuji ^a   Sugino, Keishi ^a   Gocho, Kyoko ^a   Homma, Sakae ^a   Ebihara, Satoru ^a  

^a TOHO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

6 min walk test; Interstitial lung disease; pulmonary rehabilitation

Indexed keywords

AGED; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSESSMENT TEST; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEATH; DIFFUSING CAPACITY FOR CARBON MONOXIDE; DYSPNEA; ENDURANCE TRAINING; EXERCISE; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG CLEARANCE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MODIFIED MEDICAL RESEARCH COUNCIL QUESTIONNAIRE; MULTIDISCIPLINARY TEAM; MUSCLE STRENGTH; NUTRITIONAL COUNSELING; OXYGEN DESATURATION; OXYGEN SATURATION; PREDICTIVE VALUE; PROSPECTIVE STUDY; PSYCHOLOGICAL COUNSELING; PULMONARY REHABILITATION; QUALITY OF LIFE; RESISTANCE TRAINING; RESPIRATION CONTROL; SCORING SYSTEM; SIX MINUTE WALK TEST; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; STRETCHING EXERCISE; TOTAL LUNG CAPACITY; WALKING; CONTROLLED CLINICAL TRIAL; KINESIOTHERAPY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PILOT STUDY; QUESTIONNAIRE; REFERENCE VALUE; VERY ELDERLY; WALK TEST;

AGED; AGED, 80 AND OVER; EXERCISE THERAPY; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; PROSPECTIVE STUDIES; REFERENCE VALUES; SURVEYS AND QUESTIONNAIRES; WALK TEST;

EID: 85070479718     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000305     Document Type: Article

References (37)

1. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014;(10): CD006322
2. Fregonese L, Eichler I. The future of the development of medicines in idiopathic pulmonary fibrosis. BMC Med. 2015;13: 239
3. Bradley B, Branley HM, Egan JJ, et al. British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 (suppl 5): v1-v58
4. Raghu G, Rochwerg B, Zhang Y, et al. American Thoracic Society; European Respiratory Society; Japanese Respiratory Society; Latin American Thoracic Association. An official ATS/ERS/JRS/ ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192 (2): e3-e19
5. Travis WD, Costabel U, Hansell DM; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classifi cation of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188 (6): 733-748
6. Walsh SL, Wells AU, Desai SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 2016;4 (7): 557-565
7. Jo HE, Corte TJ, Moodley Y, et al. Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. BMC Pulm Med. 2016;16: 22
8. ATS Committee on Profi ciency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166 (1): 111-117
9. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fi brotic interstitial pneumonia. Am J Respir Crit Care Med. 2005;171 (10): 1150-1157
10. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minutewalk test. Am J Respir Crit Care Med. 2006;174 (7): 803-809
11. Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174 (6): 659-664
12. du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011;183 (9): 1231-1237
13. Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefi ts and predictors of response Chest. 2009;135 (2): 442-447
14. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014;108 (1): 203-210
15. Spielmanns M, Gloeckl R, Schmoor C, et al. Effects on pulmonary rehabilitation in patients with COPD or ILD: a retrospective analysis of clinical and functional predictors with particular emphasis on gender. Respir Med. 2016;113: 8-14
16. Enright PL. The six-minute walk test. Respir Care. 2003;48 (8): 783-785
17. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158 (5, pt 1): 1384-1387
18. Andrianopoulos V, Holland AE, Singh SJ, et al. Six-minute walk distance in patients with chronic obstructive pulmonary disease: which reference equations should we use? Chron Respir Dis 2015;12 (2): 111-119
19. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force Standardisation of spirometry. Eur Respir J. 2005;26 (2): 319-338
20. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single- breath determination of carbon monoxide uptake in the lung Eur Respir J. 2005;26 (4): 720-735
21. Vogelmeier C, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 report. Global Initiative for Chronic Lung Disease. http://www.goldcopd.org/gold-2017-global-strategy-diagnosis- management-prevention-copd. Accessed August 24, 2017.
22. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116 (5): 1175-1182
23. Nagata K, Tomii K, Otsuka K, et al. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology. 2012;17 (3): 506-512
24. Katoh M. Reliability of isometric knee extension muscle strength measurements made by a hand-held dynamometer and a belt: a comparison of two types of device. J Phys Ther Sci. 2015;27 (3): 851-854
25. el-Manshawi A, Killian KJ, Summers E, Jones NL. Breathlessness during exercise with and without resistive loading. J Appl Physiol 1986;61: 896-905
26. Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefi t? Breathe (Sheff). 2016;12 (2): 130-138
27. Vainshelboim B, Fox BD, Oliveira J, Kramer MR. Exercise training in idiopathic pulmonary fibrosis. Expert Rev Respir Med 2016;10 (1): 69-77
28. Ozalevli S, Karaali HK, Ilgin D, Ucan ES. Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2010;5 (1): 31-37
29. Rammaert B, Leroy S, Cavestri B, Wallaert B, Grosbois JM. Homebased pulmonary rehabilitation in idiopathic pulmonary fibrosis Rev Mal Respir. 2011;28 (7): e52-e57
30. Jastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57 (suppl 4): S139-S148
31. Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise training- based pulmonary rehabilitation program is clinically benefi cial for idiopathic pulmonary fibrosis. Respiration. 2014;88 (5): 378-388
32. Vainshelboim B, Oliveira J, Fox BD, Soreck Y, Fruchter O, Kramer MR. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015;193 (3): 345-354
33. Vainshelboim B, Fox BD, Kramer MR, Izhakian S, Gershman E, Oliveira J. Short-term improvement in physical activity and body composition after supervised exercise training program in idiopathic pulmonary fibrosis. Arch Phys Med Rehabil. 2016;97 (5): 788-797
34. Han MK, Curran-Everett D, Dransfield MT, et al. COPDGene Investigators. Racial differences in quality of life in patients with COPD. Chest. 2011;140 (5): 1169-1176
35. Kwok BC, Pua YH, Mamun K, Wong WP. The minimal clinically important difference of six-minute walk in Asian older adults BMC Geriatr. 2013;13: 23
36. Caram LM, Ferrari R, Bertani AL, et al. Smoking and early COPD as independent predictors of body composition, exercise capacity, and health status. PLoS One. 2016;11 (10): e0164290
37. Ben Saad H, Babba M, Boukamcha R, et al. Investigation of exclusive narghile smokers: defi ciency and incapacity measured by spirometry and 6-minute walk test. Respir Care. 2014;59 (11): 1696-1709